Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Malone

Showing results (551-560 of 685) with videos related to

Pageof 69
Sort By:
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|June 26, 2003
Lower CSF homovanillic acid levels in depressed patients with a history of alcoholismLeo Sher, Maria A Oquendo, Shuhua Li, et al.
Anti-Cancer Drugs|April 1, 1993
Inhibition of c-myc in breast and ovarian carcinoma cells by 1,25-dihydroxyvitamin D3, retinoic acid and dexamethasoneD E Saunders, C Christensen, N L Wappler, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|March 17, 2005
Positron emission tomography of regional brain metabolic responses to a serotonergic challenge in major depressive disorder with and without borderline personality disorderMaria A Oquendo, Aleksandra Krunic, Ramin V Parsey, et al.
Journal of Cancer Research and Clinical Oncology|January 1, 1990
Detoxifying enzymes in human ovarian tissues: comparison of normal and tumor tissues and effects of chemotherapyZ Djuric, V K Malviya, G Deppe, et al.
The American Journal of Managed Care|May 12, 2006
Labor characteristics and program costs of a successful diabetes disease management programRussell L Rothman, Stephanie A So, John Shin, et al.
Molecular Psychiatry|October 14, 2000
Evidence for the serotonin HTR2A receptor gene as a susceptibility factor in attention deficit hyperactivity disorder (ADHD)J F Quist, C L Barr, R Schachar, et al.
Gynecologic Oncology|November 1, 1993
Additive inhibition of RL95-2 endometrial carcinoma cell growth by carboplatin and 1,25 dihydroxyvitamin D3D E Saunders, C Christensen, N L Wappler, et al.
Molecular Psychiatry|January 31, 2003
The serotonin 5-HT1B receptor gene and attention deficit hyperactivity disorderJ F Quist, C L Barr, R Schachar, et al.
Heart (British Cardiac Society)|August 11, 2007
Hypocalcaemia and vitamin D deficiency: an important, but preventable, cause of life-threatening infant heart failureS Maiya, I Sullivan, J Allgrove, et al.
Anti-Cancer Drugs|August 1, 1995
Inhibition of breast and ovarian carcinoma cell growth by 1,25-dihydroxyvitamin D3 combined with retinoic acid or dexamethasoneD E Saunders, C Christensen, J R Williams, et al.
Pageof 69

Showing results (551-560 of 685) with videos related to

Sort By:
Pageof 69
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|June 26, 2003
Lower CSF homovanillic acid levels in depressed patients with a history of alcoholismLeo Sher, Maria A Oquendo, Shuhua Li, et al.
Anti-Cancer Drugs|April 1, 1993
Inhibition of c-myc in breast and ovarian carcinoma cells by 1,25-dihydroxyvitamin D3, retinoic acid and dexamethasoneD E Saunders, C Christensen, N L Wappler, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|March 17, 2005
Positron emission tomography of regional brain metabolic responses to a serotonergic challenge in major depressive disorder with and without borderline personality disorderMaria A Oquendo, Aleksandra Krunic, Ramin V Parsey, et al.
Journal of Cancer Research and Clinical Oncology|January 1, 1990
Detoxifying enzymes in human ovarian tissues: comparison of normal and tumor tissues and effects of chemotherapyZ Djuric, V K Malviya, G Deppe, et al.
The American Journal of Managed Care|May 12, 2006
Labor characteristics and program costs of a successful diabetes disease management programRussell L Rothman, Stephanie A So, John Shin, et al.
Molecular Psychiatry|October 14, 2000
Evidence for the serotonin HTR2A receptor gene as a susceptibility factor in attention deficit hyperactivity disorder (ADHD)J F Quist, C L Barr, R Schachar, et al.
Gynecologic Oncology|November 1, 1993
Additive inhibition of RL95-2 endometrial carcinoma cell growth by carboplatin and 1,25 dihydroxyvitamin D3D E Saunders, C Christensen, N L Wappler, et al.
Molecular Psychiatry|January 31, 2003
The serotonin 5-HT1B receptor gene and attention deficit hyperactivity disorderJ F Quist, C L Barr, R Schachar, et al.
Heart (British Cardiac Society)|August 11, 2007
Hypocalcaemia and vitamin D deficiency: an important, but preventable, cause of life-threatening infant heart failureS Maiya, I Sullivan, J Allgrove, et al.
Anti-Cancer Drugs|August 1, 1995
Inhibition of breast and ovarian carcinoma cell growth by 1,25-dihydroxyvitamin D3 combined with retinoic acid or dexamethasoneD E Saunders, C Christensen, J R Williams, et al.
Pageof 69